MetaCap

Cue Biopharma Statistics

NASDAQ: CUEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.15-0.35 (-7.78%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cue Biopharma by the numbers

Cue Biopharma has a market capitalization of $34.7 million based on 8.36M shares outstanding. With trailing EPS of $-27.80, Cue Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 80.8% below its 50-day average and 80.7% below its 200-day average.

Average daily trading volume is 567.02K shares, or about $2.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CUE valuation vs. peer median

CUE compared with the median of 8 peer companies
MetricCUEPeer medianDifference
Market cap$34.69M$33.05M+5%
Avg. volume567.02K225.85K+151%

Peer median across 8 companies: GRCE, VERU, ATNM, HYFT, PLRX, SDEV, GRDX, FLNA.

Valuation

Market cap
$34.69M
Price / sales (latest FY)
1.26
EPS (TTM)
$-27.80

Price and trading

Previous close
4.50
Open
4.52
Day range
4.05 – 4.90
52-week range
2.83 – 45.50
52-week change
-76.75%
Beta
—
Volume
1.26M

Dividends and events

Annual dividend
None
Next earnings date
Aug 12, 2025

Additional statistics

Market Cap
34.69M
Forward Pe
-8.65
Eps
-27.80
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
45.50
Week52 Low
2.83
Avg Volume
567.02K
Shares Outstanding
8.36M
Ma50
21.65
Ma200
21.48
Earnings Date
Aug 12, 2025
Pct From52w High
-90.88%
Pct From52w Low
46.64%

Related